
Sucralfate
CAS No. 54182-58-0
Sucralfate( —— )
Catalog No. M14940 CAS No. 54182-58-0
Sucralfate is a cytoprotective agent, an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | 39 | In Stock |
![]() ![]() |
500MG | 60 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSucralfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSucralfate is a cytoprotective agent, an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.
-
DescriptionSucralfate is a cytoprotective agent, an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.
-
In Vitro——
-
In VivoSucralfate is a cytoprotective agent which has been employed for prevention and treatment of several gastrointestinal diseases. Enemas containing Sucralfate improves the inflammation and increases the tissue contents of neutral and acid mucins. The content of neutral mucins does not change with the time or concentration of Sucralfate used, while acid mucins increases with concentration and time of intervention. A significant increase in tissue content of neutral mucins in animals subjected to irrigation with Sucralfate (SCF) is found compare to animals irrigated with S.F. 0.9%, regardless of the concentration and duration of intervention.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorFGF2| Fibrinogen chain| Pepsin| PGF
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number54182-58-0
-
Formula Weight2086.75
-
Molecular FormulaC12H54Al16O75S8
-
Purity>98% (HPLC)
-
SolubilityInsoluble in cold Water
-
SMILESO.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(O)(=O)=O)O[C@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]1OS(O)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Terao N, et al. Arzneimittelforschung. 1980;30(1):76-8.
molnova catalog



related products
-
Lucitanib
Lucitanib is a novel VEGFR and FGFR inhibitor.
-
Amlexanox
Amlexanox (AA673; CHX3673) is a specific inhibitor of IKKε and TBK1; inhibition of IKKε and TBK1 activity as determined by MBP phosphorylation showing an IC50 of approximately 1–2 μM.
-
Aprutumab
Aprutumab (BAY 1179470) is a human FGFR2 monoclonal antibody with affinity to FGFR2 isoforms FGFR2-IIIB and FGFR2-IIIC. Aprutumab is commonly used to synthesize antibody-drug conjugates.